However, CLDN19 is expressed in human eye, and CLDN19 mutations add ocular involvement to FHHNC (FHHNCOI)6–8. The gene discussed is CLDN19; the disease is familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis.